Life Extension Foundation – Wikipedia

The Life Extension Foundation (LEF) is a nonprofit organization, whose aim is to extend the healthy human lifespan by discovering scientific methods to control aging and eradicate disease. It is headquartered in Fort Lauderdale, Florida. According to its 2009 Form 990 , it had assets of over $25 million and netted more than $3 million on revenue of more than $18 million that year. [1]

It was founded by Saul Kent and William Faloon in 1980.[2][3] It claims that its primary purpose is to fund research[4] and disseminate information on life extension, preventive medicine, anti-aging and optimal health as well as sports performance, with a focus on hormonal and nutritional supplementation, deriving much of its income from the sale of vitamins and supplements.

In May 2013, the Internal Revenue Service revoked the Life Extension Foundations tax-exempt status, retroactive to 2006.[5] Forbes reported that "The IRS problem with the Foundation is [...] an entirely worldly one: it asserts the membership organizations operations seem to be too entwined with the for-profit Life Extension Buyers Club."[6] LEF filed a Complaint for Declaratory Judgment on August 7, 2013, in U.S. District Court for the District of Columbia challenging the IRS' allegations.[7] The case is pending.[8]

In 1980 - 1981 they recommended people to consume high doses of antioxidant vitamins to maintain their health, take DHEA to slow aging and B-complex vitamins to lower homocysteine blood levels. In 1983 they were the first to recommend the Japanese cardiac drug coenzyme Q10 (CoQ10) as an anti-aging nutrient. In 1985 they published an article where they assumed that AIDS could be slowed by vitamin supplementation. In 1991 the company sued the United States Food and Drug Administration (FDA) because the FDA didn't approve Tacrine (THA) to treat Alzheimer's disease. In 1996, Life Extension published the first book where they told about preventing and treating 110 diseases.[9]

In 1997 they introduced a compound called s-adenosyl-methionine (SAMe) that helped to deal with depression, arthritis, and certain liver disorders.

In 1998 the FDA approved the anti-viral drug ribavirin for use in hepatitis C patients.

In 2000 they conducted original research using carotid ultrasound tests to show that taking high doses of antioxidants over an extended period of time may provide some protection against atherosclerosis.

In 2001 they recommended memantine to treat Alzheimer's disease and Parkinsons disease, which was approved by the FDA. In 2005 they introduced a form of coenzyme Q10 ubiquinol which has a good blood- absorbing qualities. In 2012 they formulated a product featuring oleuropein. In 2014 they formulated a series of supplements containing the polyphenol gastrodin to support brain function. [10]

See the original post:

Life Extension Foundation - Wikipedia

Related Post

Comments are closed.